Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer - 23/08/19
ABSTRACT |
OBJECTIVE |
To evaluate programmed death ligand 1 (PD-L1) staining fidelity between the primary tumor and associated lymph node metastases in bladder cancer. To secondarily evaluate whether neoadjuvant chemotherapy (NAC) affects this relationship.
METHODS |
Sixty-seven subjects with residual bladder cancer on cystectomy and associated positive lymph nodes were identified between 2008 and 2015. PD-L1 staining of tumor cells was evaluated using H score and 49 specimens were also evaluated using combined positive score (CPS). Univariable and multivariable logistic regression analysis were used to assess how various clinical variables affected odds of PD-L1 fidelity between primary and metastatic tumors.
RESULTS |
Tumor PD-L1 staining was concordant in 79.1% of cases and CPS was concordant in 79.6% of cases. NAC did not significantly impact odds of PD-L1 or CPS fidelity (OR 1.974, 95% CI 0.673-5.784, OR 0.500, 95% CI 0.093-2.700). Among clinical variables analyzed on univariable analysis of tumor PD-L1 fidelity, H-score, and PD-L1 staining intensity were associated with significantly increased odds of PD-L1 fidelity and the association with staining intensity was confirmed on multivariable analysis.
CONCLUSION |
PD-L1 fidelity between primary bladder tumors and nodal metastases was observed in >75% of cases in this study. Additionally, NAC was not shown to diminish this propensity to maintain PD-L1 staining status. Further standardization of immunohistochemistry of tumor and infiltrating imsmune cells in metastatic bladder cancer is needed to improve application of therapeutics.
Le texte complet de cet article est disponible en PDF.Plan
| Funding: Castleman Family Research Fund, The Gary Johnson Research Fund, The Bruce Shelly Research Fund, The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust, and the Translational Research Program in the Department of Pathology and Laboratory Medicine at Weill Cornell. |
|
| Conflict of Interest: All the authors declare no conflict of interest. |
Vol 131
P. 150-156 - septembre 2019 Retour au numéro
Article précédent
- High Inguinal Microsurgical Denervation of the Spermatic Cord for Chronic Scrotal Content Pain: A Novel Approach for Adult and Pediatric Patients
- Koji Shiraishi, Masanori Tabara, Hideyasu Matsuyama
- Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor
- Ashwin S. Balakrishnan, Shoujun Zhao, Janet E. Cowan, Jeanette M. Broering, Matthew R. Cooperberg, Peter R. Carroll
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?